Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?
Katharina Dendl, Stefan A. Koerber, Clemens Kratochwil, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4946-4946
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
Zhennan Yuan, Yingpu Li, Sifan Zhang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 295
FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease
Yuriko Mori, Katharina Dendl, Jens Cardinale, et al.
Radiology (2023) Vol. 306, Iss. 2
Closed Access | Times Cited: 145
68Ga Fibroblast Activation Protein Inhibitor PET/CT in the Detection of Metastatic Thyroid Cancer: Comparison with 18F-FDG PET/CT
Hao Fu, Jing Wu, Jingxiong Huang, et al.
Radiology (2022) Vol. 304, Iss. 2, pp. 397-405
Closed Access | Times Cited: 43
Head-to-head evaluation of [18F]FDG and [68 Ga]Ga-DOTA-FAPI-04 PET/CT in recurrent soft tissue sarcoma
Bingxin Gu, Xin Liu, Shuoer Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2889-2901
Open Access | Times Cited: 39
Skin Cancer Pathobiology at a Glance: A Focus on Imaging Techniques and Their Potential for Improved Diagnosis and Surveillance in Clinical Cohorts
Elena-Georgiana Dobre, Mihaela Surcel, Carolina Constantin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1079-1079
Open Access | Times Cited: 25
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides
Richard P. Baum, Emil Novruzov, Tianzhi Zhao, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 4, pp. 537-556
Closed Access | Times Cited: 8
Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74
Iris K. Lee, Estela Noguera-Ortega, Zebin Xiao, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 24, pp. 5330-5342
Open Access | Times Cited: 31
FAPI PET Opens a New Window to Understanding Immune-Mediated Inflammatory Diseases
Torsten Kuwert, Christian Schmidkonz, Olaf Prante, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 8, pp. 1136-1137
Open Access | Times Cited: 27
FAPI PET/CT in Diagnostic and Treatment Management of Colorectal Cancer: Review of Current Research Status
Zhiming Cheng, Shu Wang, Shuoyan Xu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 577-577
Open Access | Times Cited: 14
Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals
Xiaona Sun, Yuxuan Wu, Xingkai Wang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 345-345
Open Access | Times Cited: 4
FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances
Sophie E. M. Veldhuijzen van Zanten, Kay Pieterman, Bas P. L. Wijnhoven, et al.
Diagnostics (2022) Vol. 12, Iss. 8, pp. 1958-1958
Open Access | Times Cited: 21
Recent Clinical Implications of FAPI
Mahshid Kiani, Safura Jokar, Leila Hassanzadeh, et al.
Clinical Nuclear Medicine (2024) Vol. 49, Iss. 11, pp. e538-e556
Closed Access | Times Cited: 3
Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma
Lena M. Unterrainer, Simon Lindner, Lennert Eismann, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 10, pp. 3571-3580
Open Access | Times Cited: 19
Clinical prospective study of Gallium 68 (68Ga)–labeled fibroblast-activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma
Jinghua Li, Kui Xu, Deliang Guo, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 7, pp. 2152-2166
Open Access | Times Cited: 10
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine
Francesco Giammarile, Peter Knoll, Diana Páez, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 3, pp. 340-344
Closed Access | Times Cited: 3
A Role of PET/MR in Breast Cancer?
Nils Martin Bruckmann, Janna Morawitz, Wolfgang P. Fendler, et al.
Seminars in Nuclear Medicine (2022) Vol. 52, Iss. 5, pp. 611-618
Closed Access | Times Cited: 17
Emerging Role of FAPI PET Imaging for the Assessment of Benign Bone and Joint Diseases
Francesco Dondi, Domenico Albano, Giorgio Treglia, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4514-4514
Open Access | Times Cited: 15
Diagnostic performance of Ga-68 FAPI 04 PET/CT in colorectal malignancies
A. S. Prashanth, Senthil Kumar Ravichander, Prasad Eswaran, et al.
Nuclear Medicine Communications (2023) Vol. 44, Iss. 4, pp. 276-283
Closed Access | Times Cited: 8
Exploring the efficacy of FAPI PET/CT in the diagnosis and treatment management of colorectal cancer: a comprehensive literature review and initial experience
Habibollah Dadgar, Nasim Norouzbeigi, Esmail Jafari, et al.
Clinical and Translational Imaging (2024) Vol. 12, Iss. 3, pp. 235-252
Closed Access | Times Cited: 2
PET/CT FAPI: Procedure and evidence review in oncology
A.P. Caresia-Aróztegui, Jazmin Rosales, M. Rodríguez Fraile, et al.
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) (2024) Vol. 43, Iss. 2, pp. 130-140
Closed Access | Times Cited: 2
Potential application of 68Ga-FAPI PET/CT for diagnosing cardiac sarcoidosis
Ritanshu Solanki, Harpreet Singh, Vansha Mehta, et al.
Journal of Nuclear Cardiology (2024) Vol. 36, pp. 101835-101835
Closed Access | Times Cited: 2
[18F] AlF-NOTA-FAPI-04 PET/CT for non-invasive assessment of tubular injury in kidney diseases
Hao Wang, Ping Zhang, Wei Wang, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 5
Open Access | Times Cited: 2
A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers
Marinus J. Hagens, Pim J. van Leeuwen, Maurits Wondergem, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 6, pp. 888-896
Closed Access | Times Cited: 2
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications
Alessandra Boschi, Luca Urso, Licia Uccelli, et al.
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases
Mariko Nakayama, Thomas A. Hope, Ali Salavati
The Cancer Journal (2024) Vol. 30, Iss. 3, pp. 210-217
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top